View in EDS

Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America.

Saved in:
Bibliographic Details
Title: Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America.
Authors: Schoonbroodt S; GSK, Rixensart, Belgium., Ichanté JL; GSK, Rixensart, Belgium., Boffé S; GSK, Wavre, Belgium., Devos N; GSK, Rixensart, Belgium., Devaster JM; GSK, Rixensart, Belgium., Taddei L; GSK, Siena, Italy., Rondini S; GSK, Siena, Italy., Arora AK; GSK, Siena, Italy., Pascal T; GSK, Wavre, Belgium., Malvaux L; GSK, Wavre, Belgium.
Source: Frontiers in microbiology [Front Microbiol] 2023 Feb 24; Vol. 13, pp. 1098133. Date of Electronic Publication: 2023 Feb 24 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101548977 Publication Model: eCollection Cited Medium: Print ISSN: 1664-302X (Print) Linking ISSN: 1664302X NLM ISO Abbreviation: Front Microbiol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36909845
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schoonbroodt+S%22">Schoonbroodt S</searchLink>; GSK, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Ichanté+JL%22">Ichanté JL</searchLink>; GSK, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Boffé+S%22">Boffé S</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Devos+N%22">Devos N</searchLink>; GSK, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Devaster+JM%22">Devaster JM</searchLink>; GSK, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Taddei+L%22">Taddei L</searchLink>; GSK, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Rondini+S%22">Rondini S</searchLink>; GSK, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Arora+AK%22">Arora AK</searchLink>; GSK, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Pascal+T%22">Pascal T</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Malvaux+L%22">Malvaux L</searchLink>; GSK, Wavre, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548977%22">Frontiers in microbiology</searchLink> [Front Microbiol] 2023 Feb 24; Vol. 13, pp. 1098133. <i>Date of Electronic Publication: </i>2023 Feb 24 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548977 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-302X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221664302X%22">1664302X </searchLink><i>NLM ISO Abbreviation: </i>Front Microbiol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36909845
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fmicb.2022.1098133
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1098133
    Titles:
      – TitleFull: Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schoonbroodt S
      – PersonEntity:
          Name:
            NameFull: Ichanté JL
      – PersonEntity:
          Name:
            NameFull: Boffé S
      – PersonEntity:
          Name:
            NameFull: Devos N
      – PersonEntity:
          Name:
            NameFull: Devaster JM
      – PersonEntity:
          Name:
            NameFull: Taddei L
      – PersonEntity:
          Name:
            NameFull: Rondini S
      – PersonEntity:
          Name:
            NameFull: Arora AK
      – PersonEntity:
          Name:
            NameFull: Pascal T
      – PersonEntity:
          Name:
            NameFull: Malvaux L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 02
              Text: 2023 Feb 24
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 1664-302X
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in microbiology
              Type: main
ResultId 1